Form 8-K - Current report:
SEC Accession No. 0001493152-22-022608
Filing Date
2022-08-15
Accepted
2022-08-15 08:15:47
Documents
14
Period of Report
2022-08-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44102
2 ex99-1.htm EX-99.1 28293
3 ex99-1_001.jpg GRAPHIC 3977
  Complete submission text file 0001493152-22-022608.txt   262310

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnxt-20220815.xsd EX-101.SCH 2959
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnxt-20220815_lab.xml EX-101.LAB 34916
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnxt-20220815_pre.xml EX-101.PRE 22789
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3880
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 221162487
SIC: 2834 Pharmaceutical Preparations